Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 114.44
    Last
  • 0.49  -0.43%
    Today's Change
  • 114.93
    Previous Close
  • Today
     
    75.88
    129.06
    52 Week Low - High
8:10 pm ET 5/29/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding793 million
Market Cap$91 billion
Return on Equity ttm43.36%
Last DividendCELG:US does not pay a dividend
Earnings
EPS: Year Actual ttm3.077
EPS: Year Est. 12/15 ttm4.755
 
EPS: Quarterly Actual 3/15 1.07
EPS: Quarterly Est. 6/15 1.15
 
Price/Earnings ttm37.19
Relative Price/Earnings--
Earnings Growth Rate42.29
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$8 billion
Net Income$2 billion
Total Assets$17 billion
Employees6,012
Web Sitewww.celgene.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!